Rethinking Acute SVT Management Podcast

Availability

On-Demand

Release on Oct 20, 2026 5:00 AM Central Daylight Time
Expires on Oct 20, 2029

Cost

$0.00

Credit Offered

No Credit Offered

This podcast will explore the evolving landscape of acute SVT management, highlighting advancements in pharmacologic therapies, outpatient treatment strategies, and patient-administered options. Expert faculty will discuss how innovations such as etripamil may fit into modern clinical practice, empowering patients to take a more active role in managing their condition and improving quality of life.

Describe the mechanism of action, clinical efficacy, and administration of intranasal etripamil for the acute treatment of supraventricular tachycardia (SVT), including its potential role in patient-directed management outside the hospital setting.
Identify important safety considerations associated with etripamil, including common adverse effects, contraindications, and considerations for use during pregnancy and lactation.
Evaluate treatment strategies for acute and recurrent SVT during pregnancy, including vagal maneuvers, pharmacologic interventions, electrical cardioversion, and catheter ablation.

Podcast Contributors

Kamala Tamirisa, MD, FHRS | UT Southwestern

Deepthy Varghese, Electrophysiology Nurse | Emory University

K. Tamirisa

Honoraria/Speaking/Consulting Fee: Zoll Medical Corporation, Boston Scientific

D. Varghese

Nothing to disclose

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):

G. Olson: No relevant financial relationships with ineligible companies to disclose.
M. Baldwin: No relevant financial relationships with ineligible companies to disclose.